Autism Disorder and Treatment Market Analysis By Type (Asperger Syndrome, Pervasive Developmental Disorder, Others), by Treatment Type (Aba, Hyperbaric Oxygen Therapy, and Others), by Drug (SSRIs, Anti-Convulsant, Others), Forecast Till 2027
New York, United States - February 16, 2022 /MarketersMedia/ —
Autism Disorder and Treatment Market Outlook
The global autism disorder and treatment market is likely to register a healthy CAGR of over 4.37% during the review timeframe, says Market Research Future (MRFR). Autism disorders (ASDs) refer to a disorder developed in a growing stage behavior substantial developmental disability for social communication and challenges in basic behavior. Researchers act, understand, and behave typically differently when going through such a disorder.
The global autism disorder and treatment market has recorded massive growth in recent years. The market's growth is being driven by the rising government funding & sponsored awareness programs, a growing number of cases, an increased number of electronic gadgets & more health plans, and the growing adoption of assistive technologies utilizing Artificial Intelligence.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1605
Autism Disorder and Treatment Market Segment Analysis
The global market for autism disorder and treatment has been fragmented into several segments based on treatment type, deployment, treatment, and region.
The global market for autism disorder and treatment is split into pervasive development disorder, disintegrative disorder, autistic disorder, Asperger syndrome, and others based on treatment type.
Based on deployment, the autism disorder and treatment market is divided into occupation therapy, speech and language therapy, applied behavior analysis (ABA), and communication and behavioral therapies.
By treatment, the global market for autism disorder and treatment is bifurcated into sleep medication, SSRIs, drug therapies, stimulants, and antipsychotic drugs.
Autism Disorder and Treatment Market Regional Insights
The global autism disorder and treatment market is studied across four major regions, including the Middle East & Africa, Asia-Pacific, Europe, and the Americas.
The MRFR report suggests that the Americas region will likely dominate the global autism disorder and treatment market. The region is further divided into South America and North America. The North American region has the maximum number of cases. The anticipated release of antipsychotics like Namenda and Latuda is likely to generate revenues across the region.
The European region will likely secure the second position in the global autism disorder and treatment market.
The Asia-Pacific regional market for autism disorder and treatment is projected to record the highest growth over the forecasted era.
The Middle East & African region is anticipated to register moderate growth over the forecasted era.
Autism Disorder and Treatment Market Competitive Analysis
The global market for autism disorder and treatment has a strong and competitive landscape. The players across the market are focusing on growing their market presence by implementing numerous growth policies such as acquisitions, mergers, and partnerships. The list of leading players in the global autism disorder and treatment market includes Saniona AB, Heptares Therapeutics Coronis Partners Ltd., Limited, Bristol-Myers Squibb, Novartis AG, Teva Pharmaceutical Industries Ltd., Allergan, Pfizer Inc., Intra-Cellular Therapies Inc., Curemark LLC, Otsuka Holdings Co., Ltd., Johnson & Johnson Services, Inc. Concern Pharma Private Limited, Merck & CO Inc., Eli Lilly and Company, and a few others.
Recent Developments
Axial Therapeutics, a prominent biotechnology company, has announced the finishing of the dosing of the first participants in an international Phase IIb clinical trial of AB-2004, a gut-targeted molecular therapy, for the treatment of irritability linked with autism spectrum disorder (ASD). The placebo-controlled, randomized, double-blind study will examine the therapy to reduce irritability. AB-2004 focuses on the microbiome-gut-brain axis and its autism part.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/autism-disorder-and-treatment-market-1605
The behavioral health division of Magellan Health, Inc., Magellan Healthcare, has introduced a pilot in partnership with Invo Healthcare to set standards of care for children with autism spectrum disorder (ASD), undertaking applied behavior analysis (ABA) treatment. The partnership is an innovative value-based care (VBC) model developed to set the benchmark for ABA treatment and measure progress against them. The model will help suppliers offer better care, enhancing results for children with ASD and those who care for them.
Browse Related Reports at:
Medical Implants Market Research Report - Global Forecast till 2027
Hyaluronic Acid Market Research Report - Global Forecast till 2027
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact Info:
Name: Market Research Future
Email: Send Email
Organization: Market Research Future (part of Wantstats Research and Media Private Limited)
Website: https://www.marketresearchfuture.com/reports/autism-disorder-and-treatment-market-1605
Source: MarketersMedia
Release ID: 89064481
